Lipoproteins, malignancy, and anticancer agents.
Peterson
C
C
Karolinska Hospital, Stockholm, Sweden.
Masquelier
M
M
Rudling
M
M
Söderberg
K
K
Vitols
S
S
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology; D002784:Cholesterol / Q000009:adverse effects; D004337:Drug Carriers / Q000494:pharmacology*; D016503:Drug Delivery Systems; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D008074:Lipoproteins / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D011973:Receptors, LDL / Q000378:metabolism
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008074:Lipoproteins; D011973:Receptors, LDL; D002784:Cholesterol